| Application number | Title of the application | Filing Date | Status |
|---|
| 08/582825 | OB PROTEIN RECEPTOR AND RELATED COMPOSITIONS AND METHODS | Jan 3, 1996 | Abandoned |
Array
(
[id] => 4033655
[patent_doc_number] => 05856161
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Tumor necrosis factor receptor-I-associated protein kinase and methods for its use'
[patent_app_type] => 1
[patent_app_number] => 8/580988
[patent_app_country] => US
[patent_app_date] => 1996-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 22139
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856161.pdf
[firstpage_image] =>[orig_patent_app_number] => 580988
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/580988 | Tumor necrosis factor receptor-I-associated protein kinase and methods for its use | Jan 2, 1996 | Issued |
Array
(
[id] => 3941993
[patent_doc_number] => 05976832
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'DNA encoding novel calcium-binding proteins'
[patent_app_type] => 1
[patent_app_number] => 8/568310
[patent_app_country] => US
[patent_app_date] => 1995-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 16730
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/976/05976832.pdf
[firstpage_image] =>[orig_patent_app_number] => 568310
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/568310 | DNA encoding novel calcium-binding proteins | Dec 5, 1995 | Issued |
| 08/568077 | MUTATIONAL VARIANTS OF MAMMALIAN PROTEINS | Dec 5, 1995 | Abandoned |
| 08/566622 | OB RECEPTOR AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BODY WEIGHT DISORDERS, INCLUDING OBESITY | Dec 3, 1995 | Abandoned |
| 08/562663 | OB RECEPTOR AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF BODY WEIGHT DISORDERS, INCLUDING OBESITY | Nov 26, 1995 | Abandoned |
| 08/558658 | MACROPHAGE DERIVED CHEMOKINE AND CHEMOKINE ANALOGS | Nov 15, 1995 | Abandoned |
| 08/553727 | RIP: NOVEL HUMAN PROTEIN INVOLVED IN TUMOR NECROSIS FACTOR SIGNAL TRANSDUCTION, AND SCREENING ASSAYS | Oct 22, 1995 | Abandoned |
Array
(
[id] => 3771998
[patent_doc_number] => 05773582
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'Tumor necrosis factor muteins'
[patent_app_type] => 1
[patent_app_number] => 8/538875
[patent_app_country] => US
[patent_app_date] => 1995-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9845
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773582.pdf
[firstpage_image] =>[orig_patent_app_number] => 538875
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/538875 | Tumor necrosis factor muteins | Oct 3, 1995 | Issued |
Array
(
[id] => 3989544
[patent_doc_number] => 05891679
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'TNF-alpha muteins and a process for preparing them'
[patent_app_type] => 1
[patent_app_number] => 8/500860
[patent_app_country] => US
[patent_app_date] => 1995-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 23
[patent_no_of_words] => 26622
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/891/05891679.pdf
[firstpage_image] =>[orig_patent_app_number] => 500860
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/500860 | TNF-alpha muteins and a process for preparing them | Sep 14, 1995 | Issued |
| 08/516263 | METHODS OF REDUCING OR MAINTAINING REDUCED LEVELS OF BLOOD LIPIDS USING OB PROTEIN COMPOSITIONS | Aug 16, 1995 | Abandoned |
| 08/504032 | HUMAN CTLA-8 AND USES OF CTLA-8 RELATED PROTEINS | Jul 18, 1995 | Pending |
Array
(
[id] => 3770263
[patent_doc_number] => 05817306
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-06
[patent_title] => 'Method for treating graft versus host disease'
[patent_app_type] => 1
[patent_app_number] => 8/484597
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10250
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/817/05817306.pdf
[firstpage_image] =>[orig_patent_app_number] => 484597
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484597 | Method for treating graft versus host disease | Jun 6, 1995 | Issued |
Array
(
[id] => 4407984
[patent_doc_number] => 06271346
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'TNF Receptors, TNF binding proteins and DNAs coding for them'
[patent_app_type] => 1
[patent_app_number] => 8/484312
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 24
[patent_no_of_words] => 24712
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/271/06271346.pdf
[firstpage_image] =>[orig_patent_app_number] => 484312
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484312 | TNF Receptors, TNF binding proteins and DNAs coding for them | Jun 6, 1995 | Issued |
Array
(
[id] => 4098833
[patent_doc_number] => 06048837
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-11
[patent_title] => 'OB polypeptides as modulators of body weight'
[patent_app_type] => 1
[patent_app_number] => 8/485942
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 35
[patent_no_of_words] => 62303
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/048/06048837.pdf
[firstpage_image] =>[orig_patent_app_number] => 485942
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/485942 | OB polypeptides as modulators of body weight | Jun 6, 1995 | Issued |
Array
(
[id] => 3792565
[patent_doc_number] => 05726148
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-10
[patent_title] => 'Method of treating metabolic bone diseases with an IL-1 receptor'
[patent_app_type] => 1
[patent_app_number] => 8/487646
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1749
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/726/05726148.pdf
[firstpage_image] =>[orig_patent_app_number] => 487646
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/487646 | Method of treating metabolic bone diseases with an IL-1 receptor | Jun 6, 1995 | Issued |
| 08/474833 | OB PROTEIN COMPOSITIONS AND METHODS | Jun 6, 1995 | Abandoned |
Array
(
[id] => 3862892
[patent_doc_number] => 05837293
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Use of interleukin-10 analogs for antagonists to treat endotoxin- or superantigen-induced toxicity'
[patent_app_type] => 1
[patent_app_number] => 8/481560
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 113
[patent_no_of_words] => 39726
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837293.pdf
[firstpage_image] =>[orig_patent_app_number] => 481560
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/481560 | Use of interleukin-10 analogs for antagonists to treat endotoxin- or superantigen-induced toxicity | Jun 6, 1995 | Issued |
Array
(
[id] => 1490569
[patent_doc_number] => 06417158
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-09
[patent_title] => 'Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF'
[patent_app_type] => B1
[patent_app_number] => 08/477638
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 24
[patent_no_of_words] => 22997
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/417/06417158.pdf
[firstpage_image] =>[orig_patent_app_number] => 08477638
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/477638 | Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF | Jun 6, 1995 | Issued |
Array
(
[id] => 4156199
[patent_doc_number] => 06124439
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-26
[patent_title] => 'OB polypeptide antibodies and method of making'
[patent_app_type] => 1
[patent_app_number] => 8/488214
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 68
[patent_no_of_words] => 60104
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/124/06124439.pdf
[firstpage_image] =>[orig_patent_app_number] => 488214
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/488214 | OB polypeptide antibodies and method of making | Jun 6, 1995 | Issued |